Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $285.93 Analyst target: $650.00 Upside: 127.33%
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. The company is headquartered in Cambridge, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.